News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Sustained funding is difficult to get in India

Date: 11/10/2016

Sustained funding is difficult to get in India

Corporate India hasn’t developed a high appetite for risk, in terms of accepting new technology. India is still evolving. Most companies like to go for tried-and-tested methods, rather than innovation.

View All